March 16, 2011
View Full PaperMultiple Myeloma
Key Points
- The aim is to review the biologic features and management strategies for multiple myeloma.
- Literature review of management techniques for multiple myeloma
- Analysis of biologic characteristics of myeloma
- Evaluation of treatment impact on survival
- Autologous stem-cell transplantation significantly improves treatment outcomes.
- Thalidomide, lenalidomide, and bortezomib contribute to extended overall survival.
- Management strategies have evolved to enhance patient care and prognosis.
Abstract
Autologous stem-cell transplantation and agents such as thalidomide, lenalidomide, and bortezomib have changed the management of myeloma and extended overall survival. This review discusses both the biologic features and the management of multiple myeloma.